AGP Executive Report
Last update: 11 hours agoPatient Access: South African medical cannabis patients say a reported freeze on new Section 21 approvals has cut off legal treatment for people with epilepsy and serious neurological conditions, after regulators moved against alleged abuse of the system. Hemp Rules: A Texas appeals court postponed arguments over state restrictions on hemp-derived THC products, leaving the challenge for three newly elected Democratic justices to hear after they take office. Texas Reform: Sen. Carol Alvarado filed a bill to legalize and regulate adult-use cannabis, while incoming Lt. Gov. Vikki Goodwin says lawmakers are weighing broader legalization or an expansion of the state’s medical program. Medical Research: India’s CSIR-IIIM cannabis project is exploring medicines for pain, cancer, epilepsy and other conditions; officials say the work is for medical and research use. Health Risks: A study links cannabis use with higher mortality among patients hospitalized for alcohol-associated hepatitis, underscoring the need for clinicians to assess substance use. Federal Guidance: Congressional researchers criticized the FDA for being nine months late in publishing legally required guidance on hemp products.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
